News

Latest Releases

U.S. Senators Tina Smith, Tom Cotton Reintroduce Bipartisan Legislation to Boost U.S. Pharmaceutical Manufacturing

WASHINGTON, D.C. — Today, Senators Tina Smith (D-MN) and Tom Cotton (R-AR) reintroduced bipartisan legislation to reduce dependence on foreign pharmaceutical manufacturing and boost production in the U.S.   The pandemic exposed our nation’s dependence on other countries for essential prescription drugs. Seventy-seven percent of key pharmaceutical ingredients come from overseas, including from China, threatening the security of the supply chain and leading to shortages of essential prescription drugs. The American Made Pharmaceuticals Act would reduce our dependence on foreign countries for pharmaceuticals by boosting production here at home. The legislation would create federal incentives to onshore manufacturing of essential medicine, while taking steps to shore up links in the supply chain. “We know that depending on foreign countries for key resources – whether it’s oil or medicine – leaves us vulnerable to global supply chain shocks and shortages,” said Sen. Smith. “This bipartisan legislation would reduce our dependence on foreign pharmaceutical manufacturing and help boost production here at home. I look forward to getting this bill across the finish line so we can relieve prescription drug shortages and build more resilient supply chains.” “The Chinese Communist Party threatened to cut off America’s access to vital drugs during the pandemic,” said Sen. Cotton. “It’s time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.” “Amneal applauds Senators Smith and Cotton on their targeted approach to increase pharmaceutical manufacturing here in the United States,” said Chirag Patel, President & Co-CEO of Amneal Pharmaceuticals.  “Ensuring that

U.S. Senator Tina Smith Presses Postmaster General to Ensure Timely Deliveries, Safe Working Conditions Ahead of Busy Holiday Season

WASHINGTON, D.C. — Today, U.S. Senator Tina Smith (D-MN) sent a letter to U.S. Postmaster General Louis DeJoy requesting information about how the Postal Service plans to ensure on-time deliveries and safe working conditions during the holiday season. Millions of Minnesotans depend of the Postal Service to pay bills, receive prescriptions, and conduct other essential business. When service is unreliable, Minnesotans can face serious consequences – from late payment fees and social security checks to days without critical prescription medications. Smith also pushed DeJoy to ensure Postal Service employees, who are often overworked during this busy time of year, are adequately supported. “The timeliness of deliveries and safety of workers are both critical issues in Minnesota, where severe weather adds a complicated dimension to the usual peak-season delivery challenges,” wrote Senator Smith. “I urge you to take every possible precaution and preparation to protect workers and ensure timely deliveries this holiday season.” In her letter, Smith requested responses to the following questions by November 23, 2023: You can find a full copy of the letter here.

U.S. Senator Tina Smith Helps Introduce Bipartisan Legislation to Strengthen Chronic Disease Management Effort

WASHINGTON, D.C. [01/16/20]—U.S. Senator Tina Smith helped introduce bipartisan legislation—led by Sens. John Thune (R-S.D.) and Tom Carper (D-Del.)—to lower health care costs by allowing high-deductible health plans to provide chronic disease prevention services—including insulin for diabetes—to plan enrollees before they reach their plan deductible. The Chronic Disease Management Act builds on legislation introduced last year, and it follows updated guidance issued by the U.S. Department of the Treasury last summer. In July of last year, the Internal Revenue Service issued a notice expanding its interpretation of what constitutes preventive care to include certain items and services that are prescribed to someone with certain

U.S. Senators Smith, Cardin, Van Hollen, Brown, Kaine, & Warner Successfully Fight to Make Protections for Federal Health Benefits During Government Shutdowns Law of the Land

WASHINGTON D.C. [01/14/20]—U.S. Senators Tina Smith (D-Minn.), and Sens. Ben Cardin (D-Md.), Chris Van Hollen (D-Md.), Sherrod Brown (D-Ohio), Tim Kaine (D-Va.), and Mark Warner (D-Va.) fought to secure protections for federal healthcare benefits in the event of a government shutdown, and these measures were signed into law in December as part of the National Defense Authorization Act (NDAA). Similar bipartisan legislation was introduced in the House by the late Rep. Elijah Cummings (D-Md.), who fought to include these measures in NDAA before his passing. The legislation ensures that workers who have qualifying life events are able to make the proper adjustments to their health insurance plans and continue dental and

U.S. Senator Tina Smith, Colleagues Slam FDA E-Cigarette Policy Riddled with Loopholes for Kid-Appealing Flavors

WASHINGTON, D.C. [01/13/20]–Today, U.S. Senator Tina Smith (D-Minn.)—a member of the Senate Health Committee—and 29 of her Senate colleagues sent a letter to the Food and Drug Administration (FDA) Commissioner criticizing the FDA’s decision to break the Administration’s promise to clear all non-tobacco flavored e-cigarette products from the market.  On January 2, the FDA announced a weak policy that includes huge exceptions regarding menthol-flavored products and any flavored e-liquids that are not in a cartridge. This comes at a time when the youth vaping epidemic has reached an all-time high. “We are deeply disappointed with the Trump Administration’s stark reversal from its September 11, 2019 commitment to

U.S. Senators Smith & Collins Call for Quick Implementation of Bipartisan Tick Act

WASHINGTON, D.C. [01/13/20]—U.S. Senators Tina Smith (D-Minn.) and Susan Collins (R-Maine) called on the Secretary of the Department of Health and Human Services (HHS) to urge quick implementation of the Kay Hagan Tick Act that Sens. Smith and Collins authored. Their bipartisan bill—signed into law in December—will improve research, prevention, diagnostics and treatment for tick-borne diseases.  “The new law is named after the late Senator Kay Hagan, who tragically died from Powassan virus, a tick-borne disease this past October. The law provides a unified approach with leadership at the federal level and resources at the local level to combat the escalating burden of tick

en_USEnglish